David L. Kleinberg
New York University
114 Papers
1.1K Citations
David L. Kleinberg is an academic researcher from New York University. The author has contributed to research in topics: Medicine & Acromegaly. The author has an hindex of 44, co-authored 114 publications. Previous affiliations of David L. Kleinberg include Veterans Health Administration & Brookdale University Hospital and Medical Center.
Chat about Author
Papers
Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline
Shlomo Melmed,Felipe F. Casanueva,Andrew R. Hoffman,David L. Kleinberg,Victor M. Montori,Janet A. Schlechte,John A.H. Wass +6 more
TL;DR: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence for diagnosis and treatment of hyperprolactinemia.
1.5K
Physical Health Monitoring of Patients With Schizophrenia
Stephen R. Marder,Susan M. Essock,Alexander L. Miller,Robert W. Buchanan,Daniel E. Casey,John M. Davis,John M. Kane,Jeffrey A. Lieberman,Nina R. Schooler,Nancy H. Covell,Scott Stroup,Ellen M. Weissman,Donna A. Wirshing,Catherine S. Hall,Leonard M. Pogach,Xavier Pi-Sunyer,J. Thomas Bigger,Alan W. Friedman,David L. Kleinberg,Steven J. Yevich,Bonnie M. Davis,Steven S. Shon +21 more
TL;DR: A consensus panel's recommendations for improving the physical health monitoring of patients with schizophrenia who are treated in outpatient settings, including regular monitoring of body mass index, plasma glucose level, lipid profiles, and signs of prolactin elevation or sexual dysfunction are discussed.
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Peter J Trainer,W. M. Drake,Laurence Katznelson,Pamela U. Freda,Herman-Bonert,van der Lely Aj,Eleni V. Dimaraki,Paul M. Stewart,K. E. Friend,Mary Lee Vance,G. M. Besser,John A. Scarlett,Michael O. Thorner,Craig Parkinson,Anne Klibanski,Powell Js,Ariel L. Barkan,Michael C. Sheppard,Malsonado M,Rose Dr,David R. Clemmons,Gudmundur Johannsson,B.-Å. Bengtsson,Stavros Stavrou,David L. Kleinberg,David M. Cook,Lawrence S. Phillips,Martin Bidlingmaier,Christian J. Strasburger,Hackett S,Kenneth A. Zib,Bennett Wf,Robert J. Davis +32 more
TL;DR: Treatment of patients who have acromegaly with pegvisomant with a growth hormone–receptor antagonist results in a reduction in serum IGF-I concentrations and in clinical improvement.
836
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
Felipe F. Casanueva,Mark E. Molitch,Janet A. Schlechte,Roger Abs,Vivien Bonert,Marcello D. Bronstein,Thierry Brue,Paolo Cappabianca,Annamaria Colao,Rudolf Fahlbusch,Hugo L. Fideleff,Moshe Hadani,Paul A. Kelly,David L. Kleinberg,Edward R. Laws,Josef Marek,Maurice F. Scanlon,Luís G. Sobrinho,John Wass,Andrea Giustina +19 more
TL;DR: These guidelines represent the current recommendations on the diagnosis and management of prolactinomas based upon comprehensive analysis and synthesis of all available data.
Guidelines for Acromegaly Management: An Update
Shlomo Melmed,Annamaria Colao,Ariel L. Barkan,Mark E. Molitch,Ashley B. Grossman,David L. Kleinberg,David R. Clemmons,Philippe Chanson,Edward R. Laws,Janet A. Schlechte,Mary Lee Vance,Ken K. Y. Ho,Andrea Giustina +12 more
TL;DR: The group developed a consensus on the approach to managing acromegaly including appropriate roles for neurosurgery, medical therapy, and radiation therapy in the management of these patients.
790